Emergent BioSolutions Inc. (EBS) Financial Analysis & Valuation | Quarter Chart
Emergent BioSolutions Inc. (EBS)
EBSPrice: $8.21
Fair Value: 🔒
🔒score
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biolo... more
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and re... more
Description
Shares
| Market Cap | $431.19M | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Joseph C. Papa Jr. |
| IPO Date | 2006-11-15 | CAGR | 0.12% |
| Employees | 900 | Website | www.emergentbiosolutions.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 4.1% | Total Yield | 4.1% |
EBS chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.02B | P/E Ratio | 8.83 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.8 | P/B Ratio | 1.18 |
| P/CF Ratio | 3.57 | P/FCF Ratio | 3.84 |
| EPS | $0.93 | EPS Growth 1Y | -124.87% |
| EPS Growth 3Y | -120.75% | EPS Growth 5Y | -83.57% |
| Revenue Growth 1Y | -28.81% | Gross Margin | — |
| Operating Margin | 0.13% | Profit Margin | 0.07% |
| ROE | 0.1% | ROA | 0.04% |
| ROCE | 0.08% | Current Ratio | 5.01 |
| Quick Ratio | 2.41 | Cash Ratio | 1.55 |
| Debt/Equity | 1.09 | Interest Coverage | 0.67 |
| Altman Z Score | 1.68 | Piotroski Score | 7 |